Pharmacotherapy of apnoea-free sleep disorders in patients with metabolic syndrome

Aim. To evaluate the effectiveness and safety of zopiclone in apnoea-free sleep disorders among patients with metabolic syndrome (MS). Material and methods. The study included 60 patients with chronic cerebrovascular disease (CerVD) and MS (mean age 53,3±11,2 years). Zopiclone was administered in th...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: O. V. Lyubshina, A. L. Vertkin, M. Yu. Maksimova
Formato: Artigo
Idioma:Russo
Publicado: «SILICEA-POLIGRAF» LLC 2010-04-01
Series:Кардиоваскулярная терапия и профилактика
Assuntos:
chronic cerebrovascular disease
metabolic syndrome
sleep disorders
insomnia
zopiclone
Acceso en liña:https://cardiovascular.elpub.ru/jour/article/view/2042
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares